RightFit
RecruitingPhase not listed

Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
65 Years and older
Sex
Male only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Biopsies

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests an educational tool to help older men with prostate cancer and their health care providers decide if and when to do fewer tests to watch the cancer. It is for men on active surveillance, which means watching the cancer with regular tests, as well as their caregivers and clinicians.

This protocol describes development and user testing of an educational shared decision making intervention to help men with prostate cancer who are on active surveillance make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Patients: Men age 65 or older.
  • Patients: Have prostate cancer that has not spread outside the prostate.
  • Patients: Have been on active surveillance for at least 12 months.
  • All participants: Speak English fluently.
  • Caregivers: Age 18 or older.
  • Caregivers: Help care for a patient who meets the study rules, such as a partner, close friend, family member, or companion.
  • Clinicians: Age 18 or older.
  • Clinicians: Provide medical care for people with prostate cancer.

Who can't join

  • Patients: Are getting treatment for another cancer, whether new or one that has come back.
  • Caregivers and clinicians: No exclusion rules are listed.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Patients Inclusion Criteria: 1. Males aged 65 or older 2. Diagnosis of localized prostate cancer 3. On active surveillance for 12 or more months 4. Fluent in English Exclusion Criteria: 1\. Receiving treatment for another cancer (primary or recurrence) Caregivers Inclusion Criteria: 1. Aged 18 or older 2. Fluent in English 3. Involved with the care of an eligible patient (i.e. partner, close friend, family member, companion) Exclusion Criteria: 4. None Clinicians Inclusion Criteria: 1. Aged 18 or older 2. Fluent in English 3. Provides clinical care for patients with prostate cancer (e.g. medical oncologists, urologists, radiation oncologists, nurse practitioners, physician assistants) Exclusion Criteria: 1\. None

Study sites (1)

TX